/Quest%20Diagnostics%2C%20Inc_%20logo%20on%20building-by%20Tada%20Images%20via%20Shutterstock.jpg)
New Jersey-based Quest Diagnostics Incorporated (DGX) provides diagnostic testing, information, and services. With a market cap of $17.2 billion, Quest Diagnostics operates through Diagnostic Information Services and Diagnostic Solutions segments. The diagnostics and research giant is expected to release its Q3 earnings before the market opens on Tuesday, Oct. 22.
Ahead of the event, analysts expect Quest Diagnostics to report a profit of $2.27 per share, up 2.3% from $2.22 per share reported in the year-ago quarter. Moreover, the company has surpassed Wall Street’s EPS projections in each of the past four quarters. Its adjusted EPS for the last reported quarter grew 2.2% year over year to $2.35, exceeding the consensus estimates by 1.7%.
